secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001193805-24-000111
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics effects 1-for-15 reverse stock split effective Jan 31, 2024
--------------------------------------------------------------------------------

- Reverse stock split at a ratio of 1-for-15, effective January 31, 2024 at 5:00 p.m. ET.
- Every 15 pre-split shares converted into 1 share; par value unchanged at $0.001.
- Common stock continues trading on Nasdaq under symbol TCRT; new CUSIP 98973P200.
- Split ratio chosen by Board on Jan 12, 2024; stockholder authority granted at June 6, 2023 annual meeting.
- Equiniti Trust Company appointed as exchange agent for processing share conversions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119380524000111/0001193805-24-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119380524000111/e619211_8k-at.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer